📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. (2019)

First Author: Ramanan AV

Attributed to: MICA: Towards using historical data for research prioritisation in children funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0215739

PubMed Identifier: 31166977

Publication URI: http://europepmc.org/abstract/MED/31166977

Type: Journal Article/Review

Volume: 14

Parent Publication: PloS one

Issue: 6

ISSN: 1932-6203